famotidine vs nizatidine
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of famotidine and nizatidine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Pepcid
Axid
Famotidine (Pepcid) reduces stomach acid. It is used to treat ulcers, heartburn, and acid reflux.
Nizatidine helps reduce stomach acid. It can treat ulcers and heartburn.
This medicine treats active duodenal ulcers and active gastric ulcers. It also treats heartburn (nonerosive GERD) and erosive esophagitis (damage to the esophagus from acid reflux). Famotidine can also treat conditions where the stomach makes too much acid, like Zollinger-Ellison syndrome. It can also lower the risk of duodenal ulcers coming back.
Nizatidine can treat active duodenal ulcers for up to 8 weeks. It can also be used long-term at a lower dose to prevent ulcers from returning. Nizatidine treats esophagitis (damage to the esophagus) and heartburn caused by GERD for up to 12 weeks. It can also treat active benign gastric ulcers for up to 8 weeks.
Famotidine is an H2 receptor antagonist. This means it blocks histamine, a substance that tells your stomach to make acid. By blocking histamine, famotidine reduces the amount of acid your stomach produces.
Nizatidine is an H2 receptor antagonist. This means it blocks histamine from attaching to cells in your stomach. By blocking histamine, the drug reduces the amount of acid your stomach makes.
- • Headache
- • Dizziness
- • Constipation
- • Diarrhea
- • Headache
- • Abdominal pain
- • Diarrhea
- • Nausea
- • Dizziness
- Nausea 7,258
- Fatigue 6,866
- Chronic Kidney Disease 6,644
- Diarrhoea 6,452
- Dyspnoea 5,202
- Chronic Kidney Disease 264
- Acute Kidney Injury 161
- Renal Failure 135
- End Stage Renal Disease 72
- Nausea 69
In elderly patients and those with kidney problems, famotidine can cause confusion, delirium, or hallucinations. If you are elderly or have kidney problems, your doctor may prescribe a lower dose. Famotidine can hide the symptoms of stomach cancer. If your symptoms don't improve, tell your doctor.
If you have kidney problems, your doctor may need to lower your dose. Before taking this medicine for a stomach ulcer, make sure it is not cancerous.
It is not known if famotidine will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. Famotidine may pass into breast milk, but it's not expected to harm the baby. Talk to your doctor about breastfeeding while taking this medicine.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if nizatidine will harm your unborn baby. Talk to your doctor if you are breastfeeding.
Also Compare, Nearby Drugs
Compare famotidine with
Compare nizatidine with
How to Read This famotidine vs nizatidine Comparison
famotidine is classified in the H2 Receptor Antagonist drug class, while nizatidine sits within the H2 Receptor Antagonist class. Because both drugs share the same classification, they are often considered interchangeable in theory, but clinical outcomes rarely track that cleanly. Both drugs are available over the counter.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, famotidine has 32,422 submissions while nizatidine has 701. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for famotidine or nizatidine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.